Jin Rong Jie
Search documents
君实生物邹建军:双轨并行守初心 破局生长赴新程|生物医药大健康2026思享汇
Jin Rong Jie· 2026-02-10 09:04
Core Insights - The Chinese biopharmaceutical industry is at a pivotal moment as it transitions from "scale and speed" to "quality and value" during the end of the 14th Five-Year Plan and the beginning of the 15th Five-Year Plan [1][3] - The company emphasizes the importance of innovation, dual-track development, and value orientation to navigate the challenges and opportunities in 2026 [1][4] Group 1: Industry Transition - The industry is experiencing a transformation focused on quality and value, moving away from previous growth models based on scale and speed [1][3] - The company aims to address the challenges of homogenization and competition by focusing on original innovation and differentiated strategies [3][4] Group 2: Globalization and Market Expansion - The company has established a global commercialization network covering over 80 countries and regions, with products launched in 40 international markets [2] - The strategy includes enhancing local patient access while expanding global partnerships to overcome international market entry barriers [4] Group 3: Innovation and Technology - The company is committed to deepening its innovation in the field of tumor immunotherapy, particularly in addressing PD-(L)1 inhibitor resistance [3] - AI technology is being leveraged to optimize operational efficiency and enhance quality, aligning with the industry's focus on sustainable development [4]
中国疾控中心:我国急性呼吸道传染病疫情总体呈下降趋势
Jin Rong Jie· 2026-02-10 09:04
中国疾控中心研究员王大燕2月10日在国家卫生健康委新闻发布会上表示,目前,急性呼吸道传染病疫 情总体呈下降趋势。全国流感疫情总体处于低流行水平,哨点医院流感病毒检测阳性率、全国报告病例 数、聚集性疫情报告数均持续下降。 财经频道更多独家策划、专家专栏,免费查阅>> 责任编辑:山上 ...
富创精密接待24家机构调研,包括淡水泉、中信资管、南方基金、银华基金等
Jin Rong Jie· 2026-02-10 09:04
Core Viewpoint - The company is focusing on a large customer strategy and enhancing its global service capabilities in the semiconductor equipment sector through platformization and international collaboration, while continuously innovating in technology and production capacity [1][3]. Group 1: Company Strategy and Operations - The company is committed to a large customer strategy, leveraging platformization and international collaboration to improve service capabilities for leading global semiconductor equipment firms [3]. - The company has established production facilities in Nantong, Beijing, and Singapore, with Nantong already in operation and the others set to gradually release capacity [4]. - The company is focusing on advanced process technology, developing specialized surface treatment techniques such as dense spraying, plasma fluorine coating, and nanofilm technology, which are already in mass production for domestic leading clients [5]. Group 2: Financial Performance and Future Outlook - The company's performance has been under pressure due to increased investments in domestic and international capacity, high-end talent acquisition, strategic material procurement, and R&D, leading to temporary cost burdens [2][6]. - As production capacity in Nantong, Beijing, and Singapore is gradually released, along with the realization of scale effects, the company expects a reduction in marginal costs and an improvement in profitability [7]. - Shareholder activity includes a planned reduction in holdings by Guotou Shanghai Fund from March to June 2026, while the largest shareholder, Shenyang Advanced Manufacturing, has been increasing its stake, with a total investment exceeding 170 million yuan [2][8].
东方金诚:2026年货币化安置和保障房收储政策有望持续扩容
Jin Rong Jie· 2026-02-10 09:04
2026年启幕"十五五"新篇,全球经济于大国博弈与技术变革中寻求平衡,中国经济则在韧性增长与结构 升级中迈向高质量发展。外部环境变幻、内需复苏、新质生产力培育及金融"五篇大文章"落地,构成新 一年核心议题。值此,金融界特别推出《启航·预见2026》栏目,聚集百位首席,拆解政策取向、解析 产业机遇、预判市场走势。 本文来源:东方金诚研究发展部 2025年12月,中央经济工作会议将"坚持内需主导,建设强大国内市场"列为2026年八大重点任务首位, 凸显扩内需对稳经济的核心作用。其中,推动房地产市场止跌回稳,是提振内需、尤其是居民消费需求 的重要一环,预计2026年房地产行业政策仍将延续边际宽松。但当前政策基调已从短期托底转向长效机 制构建,政策制定更加注重短期刺激与长期机制的协调配合,这意味着2026年短期刺激政策的力度和节 奏不会明显强于2025年。 从需求端来看,在各类购房限制性措施已基本取消、未来边际松动空间不大的情况下,2026年房地产需 求端政策的核心是引导实际购房贷款利率下行。 2022年以来,房地产支持政策频出,其中,房贷利率累计下调约250bp,但房地产市场下跌势头不止, 对房贷利率下调似乎已不再 ...
中诚信国际研究院:于变局中开新局,寻求新均衡的2026
Jin Rong Jie· 2026-02-10 09:04
2026年启幕"十五五"新篇,全球经济于大国博弈与技术变革中寻求平衡,中国经济则在韧性增长与结构 升级中迈向高质量发展。外部环境变幻、内需复苏、新质生产力培育及金融"五篇大文章"落地,构成新 一年核心议题。值此,金融界特别推出《启航·预见2026》栏目,聚集百位首席,拆解政策取向、解析 产业机遇、预判市场走势。 本文来源:中诚信国际研究院 2025年全年经济守住5%增速目标,经济总量历史性突破140万亿元,但也凸显了经济转型阶段所特有的 结构性承压特征。从增长趋势看,全年呈现"前高后低"的运行特征,名义增速仍落后于实际增速,宏微 观温差已三年没有明显改善。经济结构延续"供强需弱"的格局,工业生产"新旧分化"、"两新"对全年经 济支撑较大但效果逐渐走弱。下半年社零和三大投资同步下滑,尤其是投资增速首次转负,在过去稳增 长时期较为罕见。 从全年经济特点看,2025年是多重变量交织下的重构之年。其一体现在DeepSeek突破下的宏观叙事重 构,中国资产迎来重估的同时,也间接推动了主体资产负债表的边际修复;其二体现在中美博弈扰动下 的出口韧性重构,在转口遭遇封堵的背景下,新兴国家工业化进程或是出口的主要拉动项;其三体 ...
工信部等5部门:到2027年,全国低空公共航路地面移动通信网络覆盖率不低于90%
Jin Rong Jie· 2026-02-10 09:04
股票频道更多独家策划、专家专栏,免费查阅>> 2月10日,工业和信息化部等五部门办公厅(秘书局、综合局、综合司)发布关于加强信息通信业能力 建设 支撑低空基础设施发展的实施意见。其中提到,坚持需求牵引、重点突出,以有条件、有需求的 低空飞行活动区域为重点,因地制宜推动信息类基础设施建设与低空应用协同发展。坚持集约复用、多 元协同,在充分利用现有公众移动通信设施等基础上,综合采用地面移动通信、卫星通信与其他通导监 技术等多元化技术手段,支撑低空应用发展。坚持试验先行、稳步推进,围绕关键技术、网络部署、应 用适配等加强试验验证,探索形成可复制的解决方案和经验做法。坚持安全可控、筑牢屏障,将网络、 数据和飞行安全保障贯穿于信息类基础设施规划、建设和运行全过程各环节。到2027年,全国低空公共 航路地面移动通信网络覆盖率不低于90%,多元融合感知方案进一步完善成熟,低空导航服务水平持续 提升,研制不少于10项信息类基础设施标准,面向城市治理、物流运输、文旅等领域形成一批典型低空 应用场景。 责任编辑:山上 ...
动漫板块集体走强,掌阅科技、中文在线、光线传媒、奥飞娱乐、华谊兄弟领涨,板块相关企业整理
Jin Rong Jie· 2026-02-10 09:04
Core Viewpoint - The animation sector is experiencing significant activity, with companies like Zhangyue Technology, Zhongwen Online, Light Media, Aofei Entertainment, and Huayi Brothers leading the gains in stock prices. Group 1: Company Highlights - Zhangyue Technology (603533.SH) has a latest stock price of 28.26 yuan, with a daily increase of +10.00%. It is a leader in the digital reading industry, with its controlling shareholder focusing on comic production [1]. - Zhongwen Online (300364.SZ) has a latest stock price of 42.34 yuan, with a daily increase of +20.01%. It is one of the largest Chinese digital publishing institutions globally and collaborates with platforms like Tencent, Bilibili, and iQIYI in the animation sector [2]. - Light Media (300251.SZ) has a latest stock price of 25.56 yuan, with a daily increase of +20.00%. The company owns two animation brands and has developed a mythological universe based on Chinese legends, covering IP production and animation teams [3]. - Aofei Entertainment (002292.SZ) has a latest stock price of 10.88 yuan, with a daily increase of +10.01%. It is a leader in the animation industry, focusing on the creation, dissemination, and operation of animation IPs, leveraging a full industry chain operation model [4]. - Huayi Brothers (300277.SZ) has a latest stock price of 2.36 yuan, with a daily increase of +14.01%. Its subsidiary is dedicated to developing and producing animated and special effects films [5].
中国建材取得微通道板氢定向还原设备与方法专利
Jin Rong Jie· 2026-02-10 08:53
Group 1 - The State Intellectual Property Office of China has granted a patent for "Microchannel Plate Hydrogen Directional Reduction Equipment and Method" to China Building Materials Science Research Institute Co., Ltd. and China National Building Material Group Corporation, with the announcement number CN119742217B and application date of November 2024 [1] - China Building Materials Science Research Institute Co., Ltd., established in 2000 and located in Beijing, focuses on technology promotion and application services, with a registered capital of 2,717.0456 million RMB. The company has invested in 36 enterprises, participated in 1,316 bidding projects, holds 21 trademark records, 2,186 patent records, and has 77 administrative licenses [1] - China National Building Material Group Corporation, founded in 1981 and also based in Beijing, primarily engages in wholesale activities, with a registered capital of 17,136.14628692 million RMB. The company has invested in 20 enterprises, participated in 5,000 bidding projects, holds 236 trademark records, 793 patent records, and has 5 administrative licenses [1]
石四药集团:国家集采接续采购中,本集团共45个品种的产品拟中标
Jin Rong Jie· 2026-02-10 08:53
Core Viewpoint - The company, 石四药集团 (Sihuan Pharmaceutical Holdings Group Ltd), is expected to have a positive impact on its business due to the anticipated successful bids for 45 product varieties in the upcoming national centralized procurement in China scheduled for February 10, 2026 [1] Group 1: Product Categories - The 45 product varieties cover multiple therapeutic areas including anti-infection, cardiovascular system, respiratory system, digestive system, and nervous system [1]
信义玻璃申请弯曲度检测装置及检测方法专利,提高检测准确性和效率
Jin Rong Jie· 2026-02-10 08:53
Group 1 - The core point of the article is that Xinyi Glass (Guangxi) Co., Ltd. has applied for a patent for a device and method for detecting curvature, which aims to improve the accuracy and efficiency of glass curvature detection [1] - The patent application, published as CN121475032A, was filed on October 2025 and pertains to the field of float glass detection technology [1] - The detection device includes a detection structure with a panel featuring scale stripes and a supporting frame, allowing for visual detection of local curvature and deformation of glass plates [1] Group 2 - Xinyi Glass (Guangxi) Co., Ltd. was established in 2017 and is located in Beihai City, primarily engaged in the non-metallic mineral products industry [2] - The company has a registered capital of 650 million RMB and has made investments in five other enterprises [2] - Xinyi Glass has participated in 2,118 bidding projects and holds 24 patents, along with 374 administrative licenses [2]